Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease

This study is currently recruiting participants.

Study NCT00831467 Information provided by CureVac GmbH

First Received: January 27, 2009 Last Updated: November 12, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	November 2010
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)